Cochrane · systematic review · CD012173
Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
Hussain, K, Murdin, L, Schilder, AGM · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
0
No studies
7
Included studies
NR
No studies 7 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: adults with Ménière's disease or syndrome
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Proportion of patients with control of vertigo or decrease in vertigo attacks | no estimate extracted | NR | No studies |
Proportion of patients with adverse effects (e.g. hyponatraemia, mood disturbance and headaches) | no estimate extracted | NR | No studies |
Proportion of patients with loss or gain of hearing/reduction in progression of hearing loss | no estimate extracted | NR | No studies |
Proportion of patients with a reduction in the severity of tinnitus | no estimate extracted | NR | No studies |
Proportion of patients with a reduction in the perception of aural fullness | no estimate extracted | NR | No studies |
Overall changes in well‐being and quality of life | no estimate extracted | NR | No studies |
Any other adverse effects | no estimate extracted | NR | No studies |